YMAB - Y-mAbs Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts7677
Avg. Estimate-0.67-0.65-2.33-1.99
Low Estimate-0.75-0.76-2.45-4
High Estimate-0.58-0.52-2.21.03
Year Ago EPS-0.42-0.47-1.5-2.33
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts7577
Avg. EstimateN/AN/AN/A35.22M
Low EstimateN/AN/AN/A1M
High EstimateN/AN/AN/A157.59M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.31-0.41-0.49-0.55
EPS Actual-0.42-0.47-0.53-0.7
Difference-0.11-0.06-0.04-0.15
Surprise %-35.50%-14.60%-8.20%-27.30%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.67-0.65-2.33-1.99
7 Days Ago-0.67-0.65-2.33-1.99
30 Days Ago-0.67-0.65-2.33-1.99
60 Days Ago-0.67-0.62-2.32-1.65
90 Days Ago-0.58-0.57-2.11-1.22
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesYMABIndustrySectorS&P 500
Current Qtr.-59.50%N/AN/A0.01
Next Qtr.-38.30%N/AN/A0.06
Current Year-55.30%N/AN/A-0.02
Next Year14.60%N/AN/A0.14
Next 5 Years (per annum)-33.50%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A